ISE-SMNE Webinar: Emerging Contributors to Residual Cardiovascular Risk

Graphic featuring SMNE and ISE logos with a background image of blood tests against a graph. Images of webinar speakers from left to right: Dr. Takahito Doi (Denmark/Japan), Dr. Daniel Elías-López (Mexico), Dr. Jean-Claude Tardif (Canada) and Moderator: Dr. Roopa Mehta (Mexico). Text reads: "Live Webinar - ISE-SMNE: Emerging Contributors to Residual Cardiovascular Risk. Thursday, 21 August 2025 4pm (CEST) / 8am (CDMX). Register today".
Join us online on Thursday, 21 August 2025, 4pm (CEST) / 8am (CDMX) for our educational session on Emerging Contributors to Residual Cardiovascular Risk. This live webinar aims to explore these emerging contributors, such as remnant cholesterol and low-grade inflammation, which have gained increasing relevance, particularly in high-risk populations like those with impaired renal function. Programme:

Start

August 21, 2025 - 4:00 pm

End

August 21, 2025 - 5:00 pm

Join us online on Thursday, 21 August 2025, 4pm (CEST) / 8am (CDMX) for our educational session on Emerging Contributors to Residual Cardiovascular Risk. This live webinar aims to explore these emerging contributors, such as remnant cholesterol and low-grade inflammation, which have gained increasing relevance, particularly in high-risk populations like those with impaired renal function.

Programme:

Moderator: Dr. Roopa Mehta (Mexico)

Speakers:

Dr. Takahito Doi (Denmark/Japan)

Topic: When Remnant Cholesterol Fuels Inflammation: A Dangerous Synergy in Cardiovascular Risk

Dr. Daniel Elías-López (Mexico)

Topic: Remnant Cholesterol, Inflammation, and chronic kidney disease: A Triple Threat for Cardiovascular Risk

Dr. Jean-Claude Tardif (Canada)

Topic: Anti-Inflammatory Therapy for Atherosclerosis: Are We Ready for the Next Frontier in Cardiovascular Prevention?

After this webinar, participants will be given the tools to:

  1. Identify sources of residual cardiovascular risk beyond LDL-cholesterol, with specific focus on remnant cholesterol and low-grade inflammation as key contributors to atherosclerotic cardiovascular disease.
  2. Explain how elevated remnant cholesterol and chronic inflammation contribute independently and synergistically to cardiovascular events in patients who have achieved LDL-cholesterol targets, including high-risk populations like those with chronic kidney disease.
  3. Describe evidence-based and emerging therapeutic approaches that address residual risk by targeting remnant cholesterol metabolism and inflammatory pathways in high-risk populations.

Register your place for free.

If you are unable to attend the live webinar, the on-demand recording will be made available on the ISE Global Educational Hub. Sign up to the ISE mailing list to be informed when it is available and how to access for free.

If you have any questions, please contact ISE Education via email: Education@isendo.org

Register your place today!

BUY NOW